Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.
and alopecia areata (AA), according to a study published in the October issue of Skin Research & Technology. Yue Zhao, from Heping Hospital Affiliated to Changzhi Medical College in China, and ...